Vaz Batista, M., Pérez-García, J. M., Cortez, P., Garrigós, L., Fernández-Abad, M., Gion, M., . . . Llombart-Cussac, A. (2024). Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: The DEBBRAH trial.
Citación estilo ChicagoVaz Batista, Marta, et al. Trastuzumab Deruxtecan in Patients With Previously Treated HER2-low Advanced Breast Cancer and Active Brain Metastases: The DEBBRAH Trial. 2024.
Cita MLAVaz Batista, Marta, et al. Trastuzumab Deruxtecan in Patients With Previously Treated HER2-low Advanced Breast Cancer and Active Brain Metastases: The DEBBRAH Trial. 2024.
Precaución: Estas citas no son 100% exactas.